Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 8273
  • Home
  • Print this page
  • Email this page

    Article Cited by others

LETTER TO EDITOR

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane

Shanmugam Mahesh P, Mythri H M, Shetty Nitin S

Year : 2007| Volume: 55| Issue : 6 | Page no: 490-491

   This article has been cited by
 
1 Macular telangiectasia type 2
Peter Charbel Issa,Mark C. Gillies,Emily Y. Chew,Alan C. Bird,Tjebo F.C. Heeren,Tunde Peto,Frank G. Holz,Hendrik P.N. Scholl
Progress in Retinal and Eye Research. 2013; 34: 49
[Pubmed]  [Google Scholar] [DOI]
2 Primitive Retinal Vascular Abnormalities: Tumors and Telangiectasias
Karl Anders Knutsson,Umberto De Benedetto,Giuseppe Querques,Claudia Del Turco,Francesco Bandello,Rosangela Lattanzio
Ophthalmologica. 2012; 228(2): 67
[Pubmed]  [Google Scholar] [DOI]
3 EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2
Raja Narayanan,Jay Chhablani,Manish Sinha,Vivek Dave,Mudit Tyagi,Rajeev R. Pappuru,Baruch D. Kuppermann
Retina. 2012; 32(10): 2001
[Pubmed]  [Google Scholar] [DOI]
4 Monthly Ranibizumab for Nonproliferative Macular Telangiectasia Type 2: A 12-Month Prospective Study
Peter Charbel Issa, Robert P. Finger, Kathrin Kruse, Sönke Baumüller, Hendrik P.N. Scholl, Frank G. Holz
American Journal of Ophthalmology. 2011; 151(5): 876
[HTML Full text]  [Google Scholar] [DOI]
5 INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF PROLIFERATIVE AND NONPROLIFERATIVE TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA :
A Brock Roller, James C Folk, Narendra M Patel, H Culver Boldt, Stephen R Russell, Michael D Abramoff, Vinit B Mahajan
Retina. 2011; 31(9): 1848
[HTML Full text]  [Google Scholar] [DOI]
6 Bevacizumab (Avastin) for the Treatment of Ocular Disease
Jonathan B. Gunther,Michael M. Altaweel
Survey of Ophthalmology. 2009; 54(3): 372
[Pubmed]  [Google Scholar] [DOI]
7 BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II
JACLYN L. KOVACH,PHILIP J. ROSENFELD
Retina. 2009; 29(1): 27
[Pubmed]  [Google Scholar] [DOI]
8 Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
KOVACH, J.L. and ROSENFELD, P.J.
Retina. 2009; 29(1): 27-32
[Pubmed]  [Google Scholar]
9 Bevacizumab (Avastin) for the Treatment of Ocular Disease
Gunther, J.B., Altaweel, M.M.
Survey of Ophthalmology. 2009; 54(3): 372-400
[Pubmed]  [Google Scholar]

 

Read this article